INTESTINAL ULTRASOUND RESPONSE AND TRANSMURAL REMISSION AFTER 48 WEEKS OF TREATMENT WITH USTEKINUMAB IN CROHN’S DISEASE: STARDUST TRIAL SUBSTUDY RESULTS BY LINE OF TREATMENT AND LOCATION

Torsten Kucharzik  ¹     Rune Wilkens  ²     Maria-Antonietta D'Agostino  ³     Giovanni Maconi  ⁴     Manuela Le Bars  ⁵     Marjolein Lahaye  ⁶     Ivana Bravatà  ⁷     Maciej Nazar  ⁸     Lioudmila Ni  ⁹     Elena Ercole  ¹⁰     Mariangela Allocca  ¹¹     Nadezda Machkova  ¹²     Floris A E de Voogd  ¹³     Carolina Palmela  ¹⁴     Rose Vaughan  ¹⁵     Christian Maaser  ^16    
1 Klinikum Lüneburg, Lüneburg, Germany
² Hvidovre Hospital, Copenhagen, Denmark
³ Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Università Cattolica del Sacro Cuore, Rome, Italy
⁴ "Luigi Sacco" University Hospital, University of Milan, Milan, Italy
⁵ Janssen-Cilag SARL, Issy-les-Moulineaux, France
⁶ Janssen-Cilag B.V., Breda, Netherlands
⁷ Janssen-Cilag S.p.A., Milan, Italy
⁸ Janssen-Cilag Polska Sp. z o.o., Warsaw, Poland
⁹ Janssen-Cilag Russia, Moscow, Russia
¹⁰ Mauriziano Hospital, Turin, Italy
¹¹ Humanitas University, Milan, Italy
¹² Clinical Center ISCARE, Prague, Czech Republic
¹³ Amsterdam University Medical Center, Amsterdam, Netherlands
¹⁴ Hospital Beatriz Ângelo, Loures, Portugal
¹⁵ The Royal Melbourne Hospital, Melbourne, Australia
¹⁶ Ambulanzzentrum Gastroenterologie am Klinikum Lüneburg, Lüneburg, Germany

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)